Health & Pharm General

Penta Security’s Cloudbric Managed Rules - API Protection Validated for Top-Tier Performance

🕔9/17/2024 12:00:00 PM

Penta Security, a leading cyber security company and provider of web application security in the Asia-Pacific region, announced that Penta Security’s latest Cloudbric Managed Rules, API Protection, showed outstanding performance in the comparative test audited by The Tolly Group.

Read Full Article

Melbourne Skin & Dermatology Launches State-of-the-Art Skin Cancer Detection and Treatment Program

🕔9/16/2024 10:35:40 PM

Melbourne Skin & Dermatology has introduced a new program focused on state-of-the-art skin cancer detection and treatment. This initiative aims to enhance the clinic’s ability to identify and address skin cancer with the latest technology and methods.

Read Full Article

HydRx Wellness Receives GMP Compliant Canadian Pharmaceutical Drug Establishment License

🕔9/16/2024 11:29:54 AM

HydRx Wellness is pleased to announce receipt of a Drug Establishment License (DEL) issued by Health Canada in accordance with the Food and Drugs Act and it’s Regulations.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) Appointment of Director

🕔9/16/2024 8:20:36 AM

Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics, is pleased to announce the appointment of James Williams to its Board as an independent nonexecutive director, effective 16 September 2024.

Read Full Article

PayToMe.co Honored as Best Ethical FinTech by Wealth & Finance International

🕔9/13/2024 8:22:40 AM

PayToMe.co, a leading innovator in AI-driven financial solutions, is proud to announce it has been named the Best Ethical FinTech Firm – North America by Wealth & Finance International.

Read Full Article

Cancer Biomarkers Market to Targets $26.97 Billion by 2027

🕔9/12/2024 6:29:20 AM

According to the report, the global cancer biomarkers industry was estimated at $10.94 billion in 2019, and is expected to hit $26.97 billion by 2027, registering a CAGR of 11.

Read Full Article

Gearing up for European Society for Medical Oncology (ESMO24) Congress with OBiS Insights Free Pre-Meeting Report

🕔9/11/2024 10:00:00 PM

OBiS, a New York City-based healthcare analytics consulting firm, has developed a pre-meeting report based on the abstract titles from the upcoming European Society of Medical Oncology (ESMO) congress.

Read Full Article